Clinical improvement in psoriasis during dithranol/UVB therapy does not correspond with a decrease in elevated serum soluble ICAM-1 levels.
Kowalzick
L
L
Universitäts-Hautklinik Hamburg-Eppendorf, Hamburg, Germany.
Bildau
H
H
Neuber
K
K
Köhler
I
I
Ring
J
J
D000328:Adult; D000875:Anthralin / Q000276:immunology / Q000627:therapeutic use*; D015703:Antigens, CD / Q000097:blood*; D015815:Cell Adhesion Molecules / Q000097:blood*; D003131:Combined Modality Therapy; D006801:Humans; D018799:Intercellular Adhesion Molecule-1; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000628:therapy*; D012995:Solubility; D014467:Ultraviolet Therapy
D015703:Antigens, CD; D015815:Cell Adhesion Molecules; D018799:Intercellular Adhesion Molecule-1; D000875:Anthralin